retatrutide effects clinical trial Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide (“reta”) is an experimental

If an individual were to regain the significant amount of weight lost, the associated hormonal suppression from aromatase and inflammation would likely return

Important Safety Note: GLP-1 medications are strictly contraindicated (must not be used) if you have a personal or family history of Medullary Thyroid Cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

doi:10.1016/j.mce.2014.12.021

Pharmacokinetic data shows receptor engagement within hours of administration

A 60 mg vial is economical at 1015 mg weekly but too large for a 12 mg microdose that would sit for months

Freezing damages the peptide structure and renders the molecule less active